Literature DB >> 22180444

Psychometric comparison of the shortened Fugl-Meyer Assessment and the streamlined Wolf Motor Function Test in stroke rehabilitation.

Tiffany Szu-Ting Fu1, Ching-Yi Wu, Keh-Chung Lin, Ching-Ju Hsieh, Jung-Sen Liu, Tien-Ni Wang, Pei Ou-Yang.   

Abstract

OBJECTIVE: We aimed to compare the responsiveness, concurrent and predictive validity of the shortened Fugl-Meyer Assessment (S-FMA) and the streamlined Wolf Motor Function Test (S-WMFT) in persons with subacute stroke.
DESIGN: Test-retest design.
SETTING: Departments of physical medicine and rehabilitation at three hospitals. PARTICIPANTS: PARTICIPANTS with first-time stroke (N = 51; 38 men, 13 women; mean age ± SD, 55.1 ± 11.7 years) based on scores of Mini-Mental State Examination and Brunnstrom stage.
INTERVENTIONS: PARTICIPANTS received one of three rehabilitation therapies for three weeks and were evaluated at baseline and end of treatment. MAIN OUTCOME MEASURES: Responsiveness was examined using the paired t-test and the standardized response mean (SRM). Criterion validity was investigated using the Pearson's correlation coefficient (r).
RESULTS: Changes from baseline to end of treatment assessed by both tests were significant (P < 0.001). The value for responsiveness of the S-FMA was significantly higher than that of the S-WMFT (SRM difference, 0.48; 95% confidence interval, 0.23-0.63). There were stronger associations between the comparison scales and the S-FMA (r = 0.57-0.68) than with the S-WMFT (r = 0.39-0.58).
CONCLUSIONS: The S-FMA had better concurrent and predictive validity than the S-WMFT and was more sensitive to changes caused by rehabilitation therapies. The S-FMA is recommended for expedited assessment of arm motor function outcome in stroke patients receiving rehabilitative therapy.

Entities:  

Mesh:

Year:  2011        PMID: 22180444     DOI: 10.1177/0269215511431474

Source DB:  PubMed          Journal:  Clin Rehabil        ISSN: 0269-2155            Impact factor:   3.477


  6 in total

1.  The effect of a therapeutic regimen of Traditional Chinese Medicine rehabilitation for post-stroke cognitive impairment: study protocol for a randomized controlled trial.

Authors:  Jia Huang; Zhengkun Lin; Qin Wang; Feiwen Liu; Jiao Liu; Yunhua Fang; Shanjia Chen; Xiaoxuan Zhou; Wenjun Hong; Jinsong Wu; Natalia Madrigal-Mora; Guohua Zheng; Shanli Yang; Jing Tao; Lidian Chen
Journal:  Trials       Date:  2015-06-16       Impact factor: 2.279

2.  Effect of a mixed reality-based intervention on arm, hand, and finger function on chronic stroke.

Authors:  Carolina Colomer; Roberto Llorens; Enrique Noé; Mariano Alcañiz
Journal:  J Neuroeng Rehabil       Date:  2016-05-11       Impact factor: 4.262

3.  Effect of Tui Na on upper limb spasticity after stroke: a randomized clinical trial.

Authors:  Meng Wang; Shouguo Liu; Zhihang Peng; Yi Zhu; Xiaodong Feng; Yihuang Gu; Jianhua Sun; Qiang Tang; Hongxia Chen; Xiaolin Huang; Jun Hu; Wei Chen; Jie Xiang; Chunxiao Wan; Gangqi Fan; Jianhu Lu; Wenguang Xia; Liping Chen; Lihua Wang; Xiao Lu; Jianan Li
Journal:  Ann Clin Transl Neurol       Date:  2019-03-19       Impact factor: 4.511

4.  Action Observation Therapy for Upper Limb Recovery in Patients with Stroke: A Randomized Controlled Pilot Study.

Authors:  Mauro Mancuso; Serena Di Tondo; Enza Costantini; Alessio Damora; Patrizio Sale; Laura Abbruzzese
Journal:  Brain Sci       Date:  2021-02-26

Review 5.  Effects of High-Frequency (HF) Repetitive Transcranial Magnetic Stimulation (rTMS) on Upper Extremity Motor Function in Stroke Patients: A Systematic Review.

Authors:  Birute Vabalaite; Laura Petruseviciene; Raimondas Savickas; Raimondas Kubilius; Povilas Ignatavicius; Egle Lendraitiene
Journal:  Medicina (Kaunas)       Date:  2021-11-07       Impact factor: 2.948

6.  The Effect of Action Observation Combined with Motor Imagery Training on Upper Extremity Function and Corticospinal Excitability in Stroke Patients: A Randomized Controlled Trial.

Authors:  Jong-Bae Choi; Seo-Won Yang; Sung-Ryong Ma
Journal:  Int J Environ Res Public Health       Date:  2022-09-23       Impact factor: 4.614

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.